Effects of Acetate or Bicarbonate Dialysis Solutions on Serum HDL and HDL Subfractions of Patients Undergoing Haemodialysis

References

• Attman P., Alaupovic P. Lipid and lipoprotein profiles of uremic dyslipoproteinemia - relation to renal function and dialysis. Nepkron 1991; 57: 401–4101. Attman P., Alaupovic P. Lipid and lipoprotein profiles of uremic dyslipoproteinemia - relation to renal function and dialysis. Nepkron 1991; 57: 401–410
   PubMed Web of Science ®Google Scholar
• Jung K., Neumann R., Precht K. Lecithin:cholesterol acyltransferase activity, HDL-cholesterol and apolipoprotein A in serum of patients undergoing chronic haemodialysis. Enzyme 1980; 25: 273–2752. Jung K., Neumann R., Precht K. Lecithin:cholesterol acyltransferase activity, HDL-cholesterol and apolipoprotein A in serum of patients undergoing chronic haemodialysis. Enzyme 1980; 25: 273–275
   PubMedGoogle Scholar
• Jug K., Scheifler A., Blank W. Changed composition of high density lipoprotein subclasses HDL2 and HDL3 after renal transplantation. Pansplant. 1988; 46: 407–4083. Jug K., Scheifler A., Blank W. Changed composition of high density lipoprotein subclasses HDL2 and HDL3 after renal transplantation. Pansplant. 1988; 46: 407–408
   Google Scholar
• Chan M. K., Varghese Z., Moorhead J. F. Lipid abnormalities in uremia, dialysis and transplantation. Kidney Int. 1981; 19: 625–6374. Chan M. K., Varghese Z., Moorhead J. F. Lipid abnormalities in uremia, dialysis and transplantation. Kidney Int. 1981; 19: 625–637
   PubMed Web of Science ®Google Scholar
• Jung K., Scheifler A., Schulze B. D. Lower serum high density lipoprotein cholesterol concentration in patients undergoing maintenance hemodialysis with acetate than with bicarbonate. Am. J. Kidney Dis. 1995; 25(4)584–5885. Jung K., Scheifler A., Schulze B. D. Lower serum high density lipoprotein cholesterol concentration in patients undergoing maintenance hemodialysis with acetate than with bicarbonate. Am. J. Kidney Dis. 1995; 25(4)584–588
   PubMed Web of Science ®Google Scholar
• Kaiser B. A., Assomull V. M., Vreman H. J. Dialysance of acetate and bicarbonate: Effect of ultrafiltration. Proc. Dial. Transplant. Forum 1979; 9: 104–1076. Kaiser B. A., Assomull V. M., Vreman H. J. Dialysance of acetate and bicarbonate: Effect of ultrafiltration. Proc. Dial. Transplant. Forum 1979; 9: 104–107
   PubMedGoogle Scholar
• Otte K. E., Lillevang T., Rasmussen K. H. Acetate or bicarbonate for hemodialysis: a randomized, double-blind controlled trial. Nephrol. Dial. Transpl. 1990; 5: 931–9367. Otte K. E., Lillevang T., Rasmussen K. H. Acetate or bicarbonate for hemodialysis: a randomized, double-blind controlled trial. Nephrol. Dial. Transpl. 1990; 5: 931–936
   PubMed Web of Science ®Google Scholar
• Giorcelli G., Dalmasso F., Bruno M. RDT with acetate-free bicarbonate buffered dialysis fluid: Long term effects on lipid pattern, acid base balance and oxygen delivery. Proc. Eur. Dial. Transpl. Assoc. 1979; 16: 1158. Giorcelli G., Dalmasso F., Bruno M. RDT with acetate-free bicarbonate buffered dialysis fluid: Long term effects on lipid pattern, acid base balance and oxygen delivery. Proc. Eur. Dial. Transpl. Assoc. 1979; 16: 115
   PubMedGoogle Scholar
• Docci D., Capponcini C., Mengozzi S. Effect of different dialysis membranes on lipid and lipoprotein serum profiles in hemodialysis patients. Nephron 1995; 69: 323–3269. Docci D., Capponcini C., Mengozzi S. Effect of different dialysis membranes on lipid and lipoprotein serum profiles in hemodialysis patients. Nephron 1995; 69: 323–326
   PubMedGoogle Scholar
• Lundberg B., Hogstrom S., Pietilainen P. Separation of plasma high density lipoprotein subclasses by a combined precipitation method using polyethylene glycol 6000 and dextran sulphate. Scand. J. Clin. Lab. Invest. 1984; 44: 305–30910. Lundberg B., Hogstrom S., Pietilainen P. Separation of plasma high density lipoprotein subclasses by a combined precipitation method using polyethylene glycol 6000 and dextran sulphate. Scand. J. Clin. Lab. Invest. 1984; 44: 305–309
   PubMed Web of Science ®Google Scholar
• Wildhalm K., Pakosta R. Precipitation with polyethylene glycol and density gradient ultracentrifugation compared for determinig high-density lipoprotein subclasses HDL2 and HDL3. Clin. Chem. 1991; 37: 238–24011. Wildhalm K., Pakosta R. Precipitation with polyethylene glycol and density gradient ultracentrifugation compared for determinig high-density lipoprotein subclasses HDL2 and HDL3. Clin. Chem. 1991; 37: 238–240
   PubMed Web of Science ®Google Scholar
• Friedewald W. T., Levy R. I., Frederickson D. S. Estimation of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin. Chem. 1976; 18: 49312. Friedewald W. T., Levy R. I., Frederickson D. S. Estimation of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin. Chem. 1976; 18: 493
   Google Scholar
• Shoji T., Nishizawa Y., Nishitani H. Impaired metabolism of high density lipoprotein in uremic patients. Kidney Int. 1992; 41: 1653–166113. Shoji T., Nishizawa Y., Nishitani H. Impaired metabolism of high density lipoprotein in uremic patients. Kidney Int. 1992; 41: 1653–1661
   PubMed Web of Science ®Google Scholar
• Miller G. J., Miller N. E. Plasma high density lipoprotein concentration and the development of ischemic heart disease. Lancet 1975; 1: 1614. Miller G. J., Miller N. E. Plasma high density lipoprotein concentration and the development of ischemic heart disease. Lancet 1975; 1: 16
   PubMed Web of Science ®Google Scholar
• Joven J., Vilella E., Ahmad S. Lipoprotein heterogeneity in end stage renal disease. Kidney Int. 1993; 43: 410–41815. Joven J., Vilella E., Ahmad S. Lipoprotein heterogeneity in end stage renal disease. Kidney Int. 1993; 43: 410–418
   PubMed Web of Science ®Google Scholar
• Schwartz C. C., Vlahcevic Z. R., Berman M. Central role of high density lipoprotein in plasma free cholesterol metabolism. J. Clin. Invest. 1982; 70: 105–11616. Schwartz C. C., Vlahcevic Z. R., Berman M. Central role of high density lipoprotein in plasma free cholesterol metabolism. J. Clin. Invest. 1982; 70: 105–116
   PubMed Web of Science ®Google Scholar
• Goldberg I. Lipoprotein metabolism in normal and uremic patients. Am. J. Kidney Dis. 1993; 21(1)87–9017. Goldberg I. Lipoprotein metabolism in normal and uremic patients. Am. J. Kidney Dis. 1993; 21(1)87–90
   PubMed Web of Science ®Google Scholar
• Glass C. K., Pittman R. C., Keller G. A. Tissue sites of apoprotein degradation in the rat. J. Biol. Chem. 1983; 258: 7161–716718. Glass C. K., Pittman R. C., Keller G. A. Tissue sites of apoprotein degradation in the rat. J. Biol. Chem. 1983; 258: 7161–7167
   PubMed Web of Science ®Google Scholar
• Dieplinger H., Schoenfeld P. Y., Fielding C. J. Plasma cholesterol metabolism in end-stage renal disease. J. Clin. Invest., 77: 1071–108319. Dieplinger H., Schoenfeld P. Y., Fielding C. J. Plasma cholesterol metabolism in end-stage renal disease. J. Clin. Invest., 77: 1071–1083
   PubMed Web of Science ®Google Scholar
• Kobayashi N., Okubo M., Marumo F., Nakamura H. Effect of dialysis on lipid metabolism in chronic renal failure: Acetate versus bicarbonate. Inf. J. Arf_q Orgs. 1983; 6: 187–19020. Kobayashi N., Okubo M., Marumo F., Nakamura H. Effect of dialysis on lipid metabolism in chronic renal failure: Acetate versus bicarbonate. Inf. J. Arfq Orgs. 1983; 6: 187–190
   PubMed Web of Science ®Google Scholar
• Akanji A. O., Bruce M. A., Frayn K. N. Effect of acetate infusion on energy expenditure and substrate oxidation rates in non-diabetic subjects. Eur. J. Clin. Nutr. 1989; 43: 107–11521. Akanji A. O., Bruce M. A., Frayn K. N. Effect of acetate infusion on energy expenditure and substrate oxidation rates in non-diabetic subjects. Eur. J. Clin. Nutr. 1989; 43: 107–115
   PubMed Web of Science ®Google Scholar
• Wheleer D. C., Sweny P., Varghese Z., Moorhead J. F. Hyperlipidemia and atherosclerosis in chronic renal dialysis patients. Replacement of renal function by dialysis. A Textbook of Dialysis, J. Maher. Kluwer, Boston 1990; 788–80722. Wheleer D. C., Sweny P., Varghese Z., Moorhead J. F. Hyperlipidemia and atherosclerosis in chronic renal dialysis patients. Replacement of renal function by dialysis. A Textbook of Dialysis, J. Maher. Kluwer, Boston 1990; 788–807
   Google Scholar
• Vincenti F., Amend W. J., Abele J. The role of hypertension in hemodialysis associated atherosclerosis. Am. J. Med. 1980; 68: 363–36923. Vincenti F., Amend W. J., Abele J. The role of hypertension in hemodialysis associated atherosclerosis. Am. J. Med. 1980; 68: 363–369
   PubMed Web of Science ®Google Scholar
• Appel G. Lipid abnormalities in renal disease. Kidney Int. 1991; 39: 169–18324. Appel G. Lipid abnormalities in renal disease. Kidney Int. 1991; 39: 169–183
   PubMed Web of Science ®Google Scholar